Visit COVID-19 resources

[Skip to Content]

Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration – (Eye Journal AOP)

14 August 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login